GDC-0927

• Description:

  GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  461.533

• Molecular Formula:

  C28H28FNO4

• Notes:

  Research use only, not for human use.

• Receptor:

  Estrogen Receptor/ERR

• CAS Number:

  1642297-01-5